SpiderRock Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$73.9M Buy
83,368
+6,331
+8% +$5.69M 1.18% 15
2024
Q2
$69.7M Buy
77,037
+7,594
+11% +$6.07M 1.4% 11
2024
Q1
$53M Buy
+69,443
New +$49.4M 1.32% 11
2017
Q2
Hold
0
178

Other funds holding LLY

SpiderRock Advisors's LLY Position: Q3 2024 in Review

SpiderRock Advisors increased its Eli Lilly (LLY) stake by 8.2% in Q3 2024, buying an estimated $5.69M and bringing the position to 83,368 shares worth $73.9M. The position accounts for 1.18% of the portfolio, ranked #15.

SpiderRock Advisors first reported a position in LLY in Q1 2024 and has held it in 3 quarters since. 3,658 funds tracked by Wall St. Rank hold LLY as of Q3 2024.

  • SpiderRock Advisors held 83,368 shares of Eli Lilly worth $73.9M as of Q3 2024.
  • SpiderRock Advisors bought 6,331 Eli Lilly shares in Q3 2024, an estimated $5.69M.
  • Eli Lilly made up 1.18% of SpiderRock Advisors's portfolio in Q3 2024, its #15 holding.
  • SpiderRock Advisors first reported a position in Eli Lilly in Q1 2024 and has held it in 3 quarters since.
  • 3,658 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2024.

Based on SpiderRock Advisors's 13F filing for Q3 2024, filed 1 Nov 2024.